Gabapentin Capsule
Product Images NDC 70518-4482

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 70518-4482). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a description of Gabapentin capsules, each containing 400 mg. The quantity provided is 90 capsules. The capsules are orange in color. The typical dosage instructions can be found in the insert included with the medication. This specific batch was repackaged by RemedyRepack Inc. in Indiana, PA. The manufacturer is Rising Pharma, Inc. located in Allendale, NJ. The medication should be kept away from children and stored at a temperature between 20-25°C (68-77°F) with excursions permitted to 15-30°C (59-86°F).*

FDA Label Image

Image (B7e57ea4 D985 4167 8c2d 716cf3c60114 01)

FDA Label Image

Image (B7e57ea4 D985 4167 8c2d 716cf3c60114 02)

This is a pain score evaluation based on the Maan Pain Score system. The text indicates a dose titration period of over 4 weeks followed by a fixed dose period. Comparisons are made between a placebo and Gabapentin at a dosage of 3600 mg per day.*

FDA Label Image

Image (B7e57ea4 D985 4167 8c2d 716cf3c60114 03)

FDA Label Image

Image (B7e57ea4 D985 4167 8c2d 716cf3c60114 04)

This text provides data on the proportion of responders (patients with at least a 50% reduction in pain score) in controlled studies on Postherpetic Neuralgia (PHN). The studies mentioned are labeled as Study 1 and Study 2. Study 1 showed 32% of patients responding positively to treatment, while Study 2 showed a response rate of 14%. The significance levels of the results are marked as p<0.001 and p<0.0001, indicating the statistical strength of the findings. The different treatment groups mentioned are Placebo (PBO), Gabapentin (GBP) at doses of 3600mg, 1800mg, and 2400mg.*

FDA Label Image

Image (B7e57ea4 D985 4167 8c2d 716cf3c60114 05)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.